183 related articles for article (PubMed ID: 33754385)
1. Astrocyte-mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome.
Reynolds KE; Wong CR; Scott AL
Glia; 2021 Jul; 69(7):1816-1832. PubMed ID: 33754385
[TBL] [Abstract][Full Text] [Related]
2. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
3. Purinergic Signalling Mediates Aberrant Excitability of Developing Neuronal Circuits in the Fmr1 Knockout Mouse Model.
Reynolds KE; Huang E; Sabbineni M; Wiseman E; Murtaza N; Ahuja D; Napier M; Murphy KM; Singh KK; Scott AL
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38652351
[TBL] [Abstract][Full Text] [Related]
4. Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3.
Reynolds KE; Krasovska V; Scott AL
J Neuroimmunol; 2021 Dec; 361():577745. PubMed ID: 34695768
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model.
Cheng C; Lau SK; Doering LC
Mol Brain; 2016 Aug; 9(1):74. PubMed ID: 27485117
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model.
Vandenberg GG; Dawson NJ; Head A; Scott GR; Scott AL
Neurochem Int; 2021 Jun; 146():105036. PubMed ID: 33785420
[TBL] [Abstract][Full Text] [Related]
8. Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of fragile X syndrome.
Yang Q; Feng B; Zhang K; Guo YY; Liu SB; Wu YM; Li XQ; Zhao MG
PLoS Genet; 2012; 8(12):e1003172. PubMed ID: 23300470
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
[TBL] [Abstract][Full Text] [Related]
10. Depletion of Mitochondrial Components from Extracellular Vesicles Secreted from Astrocytes in a Mouse Model of Fragile X Syndrome.
Ha BG; Heo JY; Jang YJ; Park TS; Choi JY; Jang WY; Jeong SJ
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401721
[TBL] [Abstract][Full Text] [Related]
11. Developmental Emergence of Phenotypes in the Auditory Brainstem Nuclei of
Rotschafer SE; Cramer KS
eNeuro; 2017; 4(6):. PubMed ID: 29291238
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
Toft AK; Lundbye CJ; Banke TG
J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
[TBL] [Abstract][Full Text] [Related]
13. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
Yuskaitis CJ; Beurel E; Jope RS
Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
[TBL] [Abstract][Full Text] [Related]
14. Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.
Nomura T; Musial TF; Marshall JJ; Zhu Y; Remmers CL; Xu J; Nicholson DA; Contractor A
J Neurosci; 2017 Nov; 37(47):11298-11310. PubMed ID: 29038238
[TBL] [Abstract][Full Text] [Related]
15. Tau reduction attenuates autism-like features in Fmr1 knockout mice.
Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW
Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects.
Vandenberg GG; Thotakura A; Scott AL
Am J Physiol Cell Physiol; 2022 Feb; 322(2):C125-C135. PubMed ID: 34817267
[TBL] [Abstract][Full Text] [Related]
17. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-induced inflammation leads to acute elevations in pro-inflammatory cytokine expression in a mouse model of Fragile X syndrome.
Hodges SL; Nolan SO; Tomac LA; Muhammad IDA; Binder MS; Taube JH; Lugo JN
Physiol Behav; 2020 Mar; 215():112776. PubMed ID: 31838149
[TBL] [Abstract][Full Text] [Related]
19. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated cholesterol metabolism, aberrant excitability and altered cell cycle of astrocytes in fragile X syndrome.
Ren B; Burkovetskaya M; Jung Y; Bergdolt L; Totusek S; Martinez-Cerdeno V; Stauch K; Korade Z; Dunaevsky A
Glia; 2023 May; 71(5):1176-1196. PubMed ID: 36594399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
